Expertise in
4
conditions

Danny De Looze

Gent, VLG, BE 
Expertise in
4
conditions
Gent, VLG, BE 

Overview

Danny De Looze practices practicing medicine in Gent, Belgium.

Mr. De Looze is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Anal Fissure, Hemorrhoids, Irritable Bowel Syndrome (IBS), Hemorrhoidectomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 42 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

Gent, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn's Disease Who Have Participated in ADMIRE II Study
A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn's Disease Who Have Participated in ADMIRE II Study
Enrollment Status: Completed
Publish Date: April 23, 2025
Intervention Type: Biological, Other
Study Drug: Darvadstrocel Adipose Stem Cell Transplantation
Study Phase: Phase 3
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Other
Study Drug: Cx601
Study Phase: Phase 3
Local Injection of Collagenase Clostridium Histolyticum (XiapexR) for Refractory Iatrogenic Esophageal Strictures: an Open-label Pilot Study
Local Injection of Collagenase Clostridium Histolyticum (XiapexR) for Refractory Iatrogenic Esophageal Strictures: an Open-label Pilot Study
Enrollment Status: Terminated
Publish Date: September 13, 2023
Intervention Type: Drug
Study Phase: Early Phase 1
Peripheral Histamine 1 Receptor Blockade in IBS
Peripheral Histamine 1 Receptor Blockade in IBS
Enrollment Status: Completed
Publish Date: February 08, 2023
Intervention Type: Drug
Study Drug: Ebastine
Study Phase: Phase 4
A Phase II, Multicentre, Randomised, Double-blind, Placebo Controlled, Proof of Concept Study of Efficacy and Safety of Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
A Phase II, Multicentre, Randomised, Double-blind, Placebo Controlled, Proof of Concept Study of Efficacy and Safety of Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating: a Double Blind, Placebo Controlled Randomised Clinical Trial
Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating: a Double Blind, Placebo Controlled Randomised Clinical Trial
Enrollment Status: Completed
Publish Date: December 08, 2017
Intervention Type: Procedure
Study Phase: Not Applicable
View 5 Less Clinical Trials

42 Total Publications

Guideline on Pelvic Floor Disorders: consensus on Obstructed Defecation Syndrome (ODS).
Guideline on Pelvic Floor Disorders: consensus on Obstructed Defecation Syndrome (ODS).
Journal: Acta gastro-enterologica Belgica
Published: July 08, 2026

Frequently Asked Questions about Danny De Looze

Is Danny De Looze a top-rated expert for Anal Fissure?

MediFind is an objective health platform that identifies experts based on real-world data. Danny De Looze is classified as an Elite expert for Anal Fissure, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Danny De Looze participate in research or clinical trials?

Yes. Danny De Looze has published 42 articles and abstracts on conditions like Anal Fissure. You can view a list of Danny De Looze's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. De Looze's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile